Cogent Biosciences Income Statement (2017-2026) | COGT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.04B	0.04B	0.04B	0.05B	0.05B	0.05B	0.05B	0.06B	0.06B	0.06B	0.06B	0.07B	0.08B	0.08B
Selling, General & Administrative (Quarter)	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.03B
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	0.02B	0.02B	0.03B	0.03B	0.04B	0.04B	0.04B	0.04B	0.05B	0.06B	0.06B	0.06B	0.06B	0.08B	0.07B	0.07B	0.08B	0.08B	0.10B	0.10B
Operating Income (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.05B	-0.06B	-0.06B	-0.06B	-0.06B	-0.08B	-0.07B	-0.07B	-0.08B	-0.08B	-0.10B	-0.10B
EBIT (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.05B	-0.06B	-0.06B	-0.06B	-0.06B	-0.08B	-0.07B	-0.07B	-0.08B	-0.08B	-0.10B	-0.10B
Non-operating items
Interest & Investment Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B
Other Non Operating Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Non Operating Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.01B	-0.00B	0.01B	0.00B	0.01B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Net income details
EBT (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.04B	-0.06B	-0.05B	-0.06B	-0.06B	-0.07B	-0.07B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Profit After Tax (Quarter)	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.01B	-0.01B			-0.06B	-0.06B	-0.07B	-0.01B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Income from Continuing Operations (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.04B	-0.06B	-0.05B	-0.06B	-0.06B	-0.07B	-0.07B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Consolidated Net Income (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.04B	-0.06B	-0.05B	-0.06B	-0.06B	-0.07B	-0.07B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Income towards Parent Company (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.04B	-0.06B	-0.05B	-0.06B	-0.06B	-0.07B	-0.07B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.04B	-0.06B	-0.05B	-0.06B	-0.06B	-0.07B	-0.07B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Additional items
EPS (Basic) (Quarter)	-0.43	-0.48	-0.62	-0.68	-0.71	-0.50	0.11	-0.42	-575.52	-0.53	-0.52	-0.49	-0.43	-0.52	-0.50	-0.52	-0.53	-0.50	-0.61	-0.53
EPS (Weighted Average and Diluted) (Quarter)	-0.43	-0.48	-0.62	-0.68	-0.71	-0.50	0.11	-106.23	-0.59	-131.46	-0.52	-0.49	-0.43	-0.52	-501.16	-0.52	-0.53	-0.50	-0.61	-0.53
Shares Outstanding (Weighted Average) (Quarter)	0.04B	0.04B	0.04B	0.05B	0.05B	0.05B	0.06B	0.00B	0.00B	0.08B	0.08B	0.09B	0.10B	0.10B	0.10B	0.11B	0.11B	0.12B	0.13B	0.16B
Shares Outstanding (Diluted Average) (Quarter)	0.04B	0.04B	0.04B	0.05B	0.05B	0.05B	0.06B		0.07B	0.00B	0.08B	0.09B	0.10B	0.11B	0.10B	0.11B	0.11B	0.14B	0.13B	0.16B
EBITDA (Quarter)	-0.02B	-0.02B	-0.02B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.04B	-0.06B	-0.05B	-0.06B	-0.06B	-0.07B	-0.07B	-0.07B	-0.07B	-0.08B	-0.10B	-0.10B
Interest Expenses (Quarter)																	0.00B	0.00B	0.00B	0.00B

Research Tools

Developers

Cogent Biosciences Income Statement (2017-2026) | COGT

Research Tools

Developers

Cogent Biosciences Income Statement (2017-2026) | COGT

Create an account

Sign In

Reset Password